Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells

被引:0
|
作者
Amirhesam Babajnai [1 ]
Saeed Rahmani [1 ]
Mohammad Jamal Asadi [2 ]
Elmira Gheytanchi [1 ]
Glavizh Adibhesami [1 ]
Faezeh Vakhshiteh [1 ]
Zahra Madjd [1 ]
机构
[1] Iran University of Medical Sciences,Oncopathology Research Center
[2] Sharif University of Technology,Department of Computer Engineering
[3] Iran University of Medical Sciences,Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine
关键词
Cancer stem cell; Colorectal cancer; 5-FU, EMT; ABC, Drug resistance;
D O I
10.1186/s12935-025-03758-2
中图分类号
学科分类号
摘要
Cancer stem cells (CSCs) as a subgroup of cells within a tumor capable of self-renewal, thereby driving tumor initiation and spread. Addressing treatment failures in cancer, linked to CSCs and their resistance mechanisms, requires effective preclinical models for testing targeted therapies. Caco2- and HT-29-resistant cells were generated by repeated treatment of cells with growing concentrations of 5-fluorouracil (5-FU) anticancer drug for an extended time. The sensitivity of 5-FU-resistant cells was evaluated by cytotoxicity assay. Stemness, epithelial-mesenchymal transition (EMT), migration and drug resistance characteristics were assessed through gene expression investigation by real-time PCR. The expression of CD44, CD133, and CD66 were evaluated by flow cytometry. To end, the bioinformatic analysis estimated the molecular function and biological pathways considering the differential expression of selected genes and proteins. 5-FU-exposed cells displayed increased resistance to 5-FU. The gene expression analysis showed an upregulation of stemness genes (KLF4, SOX2, OCT4, C-MYC), enhanced scavenging system, and elevated expression of CSC surface markers (CD44 and CD133) compared to parental cells. Additionally, pro-EMT genes (TWIST1, SNAIL1, ZEB1, Vimentin, and N-cadherin) were significantly upregulated compared to parental cells, with the downregulation of E-cadherin as an EMT suppressor gene reflected in increased migration capacity. Moreover, increased expression of ABC transporter genes (ABCB1, ABCC1) was observed, correlating with enhanced drug resistance. The bioinformatic analysis highlighted pathways related to microRNAs in cancer, cells pluripotency, and proteoglycans. Methods of drug exposure take priority over spheroid formation, particularly due to their enhanced efficacy in stemness, EMT, and surface markers. This positions them as a promising protocol for establishing experimental models of CSCs.
引用
收藏
相关论文
共 50 条
  • [1] Epigenetic Mechanism of Enrichment of A549 Lung Cancer Stem Cells with 5-Fu
    Cao, Fangyuan
    Shi, Mumu
    Yu, Bo
    Cheng, Xiangrong
    Li, Xin
    Pa, Xinshan
    ONCOTARGETS AND THERAPY, 2021, 14 : 3783 - 3794
  • [2] Doxifluridine in patients with 5-FU resistant colorectal cancer
    Bajetta, E
    DiBartolomeo, M
    Somma, L
    Vicario, G
    Celio, L
    Bignami, P
    Bandieri, E
    Baldini, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 705 - 705
  • [3] Phenotypic characterization of human colorectal cancer stem cells
    Dalerba, Piero
    Dylla, Scott J.
    Park, In-Kyung
    Liu, Rui
    Wang, Xinhao
    Cho, Robert W.
    Hoey, Timothy
    Gurney, Austin
    Huang, Emina H.
    Simeone, Diane M.
    Shelton, Andrew A.
    Parmiani, Giorgio
    Castelli, Chiara
    Clarke, Michael F.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (24) : 10158 - 10163
  • [4] Effects of Carbon Ion Beam Alone or in Combination with 5-FU on Colorectal Cancer Stem Cells In Vitro
    Koom, Woong Sub
    Sai, Sei
    Takizawa, Kazuya
    Suzuki, Masao
    Fujimori, Akira
    Yamada, Shigeru
    Kamada, Tadashi
    Tsujii, Hirohiko
    CANCER SCIENCE, 2018, 109 : 1311 - 1311
  • [5] Colorectal cancer - Is there an alternative to 5-FU?
    Bleiberg, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (04) : 536 - 541
  • [6] Combined administration of 5-FU with CDHP exert synergistic antitumor effect for 5-FU resistant gastric cancer cells
    Sasaki, E
    Tominaga, K
    Kuwamura, H
    Watanabe, T
    Fujiwara, Y
    Oshitani, N
    Higuchi, K
    Arakawa, T
    Proceedings of the 6th International Gastric Cancer Congress, 2005, : 229 - 231
  • [7] BET inhibitor bromosporine enhances 5-FU effect in colorectal cancer cells
    Cheng, Xueyuan
    Huang, Zhong
    Long, Di
    Jin, Wei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 521 (04) : 840 - 845
  • [8] Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
    He, Lingfeng
    Zhu, Hong
    Zhou, Shiying
    Wu, Ting
    Wu, Huan
    Yang, Huan
    Mao, Huiwen
    SekharKathera, Chandra
    Janardhan, Avilala
    Edick, Ashlin M.
    Zhang, Anna
    Hu, Zhigang
    Pan, Feiyan
    Guo, Zhigang
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 : 1 - 12
  • [9] Synthesis and Chemopreventive Potential of 5-FU/Genistein Hybrids on Colorectal Cancer Cells
    Moreno-Quintero, Gustavo
    Castrillon-Lopez, Wilson
    Herrera-Ramirez, Angie
    Yepes-Perez, Andres F.
    Quintero-Saumeth, Jorge
    Cardona-Galeano, Wilson
    PHARMACEUTICALS, 2022, 15 (10)
  • [10] Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression
    Choi, Seungho
    Ku, Ja-Lok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 412 (02) : 207 - 213